Richard H. Scheller
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard H. Scheller
Richard H. Scheller was last confirmed as Chairman at BridgeBio Pharma, Inc. (BBIO) in a filing dated April 22, 2020. Earlier roles on record: Board Member at BridgeBio Pharma, Inc. (BBIO) until February 21, 2023. BridgeBio Pharma, Inc. reported in an 8-K filed February 23, 2023 that Richard H. Scheller resigned as member of the Board of Directors, effective February 21, 2023.
“On February 21, 2023, Richard H. Scheller, Ph.D. and Brenton L. Saunders each notified BridgeBio Pharma, Inc. (the "Company"), of his decision to resign as a member of the Board of Directors of the Company (the "Board") effective as of February 21, 2023, and on or about March 6, 2023, respectively.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2020-04-22
Last confirmed by a filing; no departure on record
-
Start not stated–2023-02-21
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.